Gland Pharma Ltd share price logo

Gland Pharma Share Price

NSE: GLAND

BSE: 543245

Small Cap

Healthcare Sector

₹1710.50

+40.30

(+2.41%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Gland Pharma Stock Performance

as on March 25, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,670.20
    ₹1,727.00
    downward going graph

    2.36%

    Downside

    0.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,277.80
    ₹2,131.00
    downward going graph

    25.30%

    Downside

    24.58%

    Upside

    downward going graph

Gland Pharma share price movements today

Previous Close
₹1,670.20
Open
₹1,689.00
Volume
58.10K
Upper Circuit
₹2,004.20
Lower Circuit
₹1,336.20
Day's Low - High
₹1,670.20 - ₹1,727.00
52 Week Low - High
₹1,277.80 - ₹2,131.00

Gland Pharma Historical Returns

1 Month Return
-9.65 %
3 Month Return
+ 1.01 %
1 Year Return
+ 2.22 %
3 Year Return
+ 32.35 %
5 Year Return
-31.85 %

Gland Pharma Fundamentals

as on March 25, 2026 at 4:01 pm IST

Market Cap

₹27,517.62 Cr

Return on Equity (ROE)

11.62

PE Ratio (TTM)

32.48

Return on capital employed (ROCE)

15.83

Industry PE ratio

40.16

Beta (LTM)

0.74

P/B Ratio

2.69

Dividend Yield

1.13

PEG Ratio

3.75

Quarterly Earnings Growth YOY

27.74

EPS (TTM)

42.4

Sector

Pharmaceuticals

Book Value

555.4

Technical Analysis

Bearish

View Technical Analysis

Gland Pharma Stock Valuation

as on March 25, 2026 at 4:01 pm IST

Gland Pharma in the last 5 years

  • Overview

  • Trends

Lowest (18.84x)

May 22, 2023

Today (32.48x)

March 24, 2026

Industry (40.16x)

March 24, 2026

Highest (67.14x)

August 12, 2021

LowHigh

Today’s Price to Earnings Ratio: 32.48x

Gland Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gland Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Gland Pharma Ltd image
Gland Pharma Ltd
BUY27,517.62-6.37%0.536985,616
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY1,59,971.3714.93%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,44,062.6949.67%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY59,819.60-1.48%0.781,42915,261
Cipla Ltd image
Cipla Ltd
BUY98,501.0110.98%0.515,29127,547
See all

Market expectation of Gland Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

60.00%

Buy

13.33%

Hold

26.67%

Sell

Gland Pharma Stock’s Investor Sentiment and Interest

Search interest for Gland Pharma Ltd Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Gland Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
785.01
1,208.69
1,373.42
1,545.16
1,537.45
1,401.71
1,405.83
1,384.05
1,424.91
1,505.62
1,486.88
1,695.36
Other Income
38.94
37.54
53.16
37.39
42.15
51.43
59.66
58.49
44.03
57.53
84.16
63.17
Total Income
823.95
1,246.24
1,426.58
1,582.55
1,579.6
1,453.14
1,465.49
1,442.55
1,468.94
1,563.15
1,571.04
1,758.54
Expenses
673.05
914.74
1,049.35
1,188.77
1,178.8
1,137.31
1,108.78
1,024.1
1,077.39
1,137.86
1,172.99
1,284.83
Operating Profit
111.96
293.95
324.07
356.39
358.65
264.4
297.05
359.95
347.52
367.76
313.89
410.53
Operating Profit Margin %
14.26%
24.32%
23.6%
23.06%
23.33%
18.86%
21.13%
26.01%
24.39%
24.43%
21.11%
24.21%
Profit Before Interest, Tax and Depreciation
150.9
331.5
377.23
393.78
400.8
315.82
356.72
418.45
391.54
425.29
398.05
473.7
Interest
2.2
4.92
6.05
5.28
9.96
5.62
6.11
22.82
7.45
11.5
7.82
3.93
Depreciation
37.54
65.32
81.3
105.34
92.61
91.96
93.83
96.33
95.76
101.05
106.31
107.65
Profit Before Tax
111.16
261.26
289.88
283.16
298.23
218.24
256.78
299.3
288.33
312.74
283.92
362.12
Tax Paid
32.47
67.16
95.8
91.31
105.81
74.48
93.24
94.61
101.79
97.26
100.23
100.65
Profit After Tax
78.68
194.1
194.08
191.86
192.42
143.76
163.53
204.69
186.54
215.48
183.68
261.48
Total Net profit including share of profit / Loss from associate company
78.68
194.1
194.08
191.86
192.42
143.76
163.53
204.69
186.54
215.48
183.68
261.48
EPS
4.78
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
Actual EPS
4.78
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
Adjusted EPS
4.78
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
Diluted EPS
4.78
11.78
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87

Gland Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,633.24
3,462.88
4,400.71
3,624.6
5,664.72
5,616.5
Other Income
139.17
134.78
223.94
240.46
170.24
213.61
Total Income
2,772.41
3,597.65
4,624.65
3,865.06
5,834.96
5,830.11
Expenses
1,677.77
2,160.65
2,890.56
2,656.3
4,331.65
4,347.58
Operating Profit
955.47
1,302.23
1,510.15
968.3
1,333.07
1,268.92
Operating Profit Margin %
36.28%
37.61%
34.32%
26.71%
23.53%
22.59%
Profit Before Interest, Tax and Depreciation
1,094.64
1,437
1,734.09
1,208.77
1,503.31
1,482.53
Interest
7.18
3.41
5.24
7.45
26.2
42
Depreciation
94.59
98.78
110.3
146.74
344.57
377.87
Profit Before Tax
992.87
1,334.81
1,618.55
1,054.58
1,132.54
1,062.66
Tax Paid
220.01
337.85
406.89
273.54
360.08
364.13
Profit After Tax
772.86
996.96
1,211.66
781.04
772.46
698.53
Total Net profit including share of profit / Loss from associate company
772.86
996.96
1,211.66
781.04
772.46
698.53
EPS
49.88
63.07
73.81
47.44
46.9
42.4
Actual EPS
49.88
63.07
73.81
47.44
46.9
42.4
Adjusted EPS
49.88
63.07
73.81
47.44
46.9
42.4
Diluted EPS
49.88
62.99
73.64
47.43
46.89
42.4

Gland Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
700.94
604.93
790.77
363.97
996.8
914.73
Cash Flow from Investing Activities
-760.96
-1,520.42
-999.3
1,211.18
-1,749.19
1,717.86
Cash Flow from Financing Activities
-6.87
1,238.46
34.89
14.92
-799.41
-433.48
Net Cash Flow
-66.91
322.97
-173.64
1,590.08
-1,551.81
2,199.12

Gland Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
57.86%
57.86%
57.86%
57.86%
51.83%
51.83%
51.83%
51.83%
51.83%
51.83%
51.83%
DII
23.38%
22.45%
23.14%
25.23%
32.83%
35.37%
34.8%
33.27%
32.85%
32.64%
32.98%
FII
0%
4.91%
0%
3.59%
6.88%
4.47%
5.04%
6.9%
7.39%
7.91%
7.58%
Public
15.96%
14.78%
13.93%
13.32%
8.45%
8.32%
8.33%
7.99%
7.93%
7.63%
7.61%
Total Outstanding Shares
16,47,00,823
16,47,00,823
16,47,01,923
16,47,10,523
16,47,51,723
16,47,51,723
16,47,51,723
16,47,56,423
16,47,56,423
16,47,56,423
16,47,56,423
Total Shareholders
1,81,747
1,61,627
1,36,021
1,22,375
1,22,665
1,22,358
1,21,075
1,13,788
1,10,671
97,151
94,578

Mutual Funds that own Gland Pharma Stock

Check out the Mutual Funds with significant holdings in Gland Pharma.

Gland Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Gland Pharma.

  • Gland Pharma Ltd Earnings Results

    Gland Pharma Ltd’s net profit jumped 27.74% since last year same period to ₹261.48Cr in the Q3 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 42.36% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Gland Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Gland Pharma Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 2.28%.

    Read More about Dividends

Indices Featuring Gland Pharma Stock

Check stock indices that include Gland Pharma.

BSE Healthcare

₹42,739.33

2.06 (▲861.80%)

S&P BSE 150 MidCap

₹14,975.17

2.34 (▲342.15%)

Nifty Smallcap 250

₹14,937.20

2.49 (▲362.95%)

Nifty MNC

₹29,086.05

2.00 (▲571.35%)

S&P BSE 250 LargeMidCap

₹10,070.67

1.88 (▲185.71%)

Nifty MidSmallcap 400

₹18,370.75

2.39 (▲428.85%)

Nifty 500

₹21,478.20

1.95 (▲411.20%)

Nifty Smallcap 50

₹7,805.45

2.73 (▲207.20%)

BSE 500

₹33,645.89

1.93 (▲636.32%)

Nifty Small 100

₹15,896.55

2.59 (▲401.35%)

NIFTY PHARMA

₹22,679.75

1.98 (▲439.95%)

S&P BSE 400 MidSmallCap

₹10,964.25

2.36 (▲252.79%)

Insights on Gland Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 30.19% to 31.42% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GLAND stock has moved up by 0.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 1.44K Cr → 1.75K Cr (in ₹), with an average increase of 4.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 183.68 Cr → 261.48 Cr (in ₹), with an average increase of 29.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 31.2% return, outperforming this stock by 29.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.83% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 177.2% return, outperforming this stock by 144.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.63% to 7.61% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.91% to 7.58% in Dec 2025 quarter

About Gland Pharma Ltd

Gland Pharma Ltd is an Indian pharmaceutical company that was founded in 1978. The company is headquartered in Hyderabad and specializes in the development and manufacture of injectable drugs and active pharmaceutical ingredients (APIs). It is one of the largest independent companies in the world that provides high-quality, cost-effective injectable products.

Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.

Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.

Revenue: ₹1,695.36Cr as on December 2025 (Q3 FY26)
Net Profit: ₹261.48Cr as on December 2025 (Q3 FY26)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
OrganisationGland Pharma Ltd
IndustryPharmaceuticals
CEOYiu Kwan Stanley Lau
E-voting on sharesClick here to vote

FAQs

What is Gland Pharma share price today?

Gland Pharma share price today stands at ₹1710.5 as on at the close of the market. Gland Pharma share today touched a day high of ₹1727 and a low of ₹1670.2.

What is the 52 week high and 52 week low range for Gland Pharma share?

Gland Pharma touched a 52 week high of ₹2131 and a 52 week low of ₹1277.8. Gland Pharma share price today i.e. is closed at ₹1710.5, which is -19.73% down from its 52 week high and 33.86% up from its 52 week low.

What is Gland Pharma's market capitalisation today?

Gland Pharma market capitalisation is ₹27,517.62 Cr as on .

How to buy Gland Pharma shares?

To buy Gland Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLAND or Gland Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Gland Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Gland Pharma trading volume today?

Gland Pharma trading volume is 58.10K as on . This means that 58.10K shares of Gland Pharma were bought and sold on the stock market during today's trading session.